☆ 4.6 Article

Reported cases of end-stage kidney disease-United States, 2000-2019

AMERICAN JOURNAL OF TRANSPLANTATION (2022)

Related references

Note: Only part of the references are listed.
Article Urology & Nephrology

Kidney, Cardiovascular, and Safety Outcomes of Canagliflozin according to Baseline Albuminuria A CREDENCE Secondary Analysis

Meg Jardine et al.

Summary: Canagliflozin can safely reduce kidney and cardiovascular events in patients with type 2 diabetes and severely increased urine albumin-to-creatinine ratio (UACR). In this population, the relative kidney benefits remain consistent across different levels of albuminuria, with the greatest absolute kidney benefit observed in those with an UACR >= 3000 mg/g.

CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2021)

Add to Collection
Article Endocrinology & Metabolism

Sustained Lower Incidence of Diabetes-Related End-Stage Kidney Disease Among American Indians and Alaska Natives, Blacks, and Hispanics in the US, 2000-2016

Nilka Rios Burrows et al.

DIABETES CARE (2020)

Add to Collection
Review Medicine, General & Internal

Meta-analysis: Effect of monotherapy and combination therapy with inhibitors of the renin-angiotensin system on proteinuria in renal disease

Regina Kunz et al.

ANNALS OF INTERNAL MEDICINE (2008)

Add to Collection
Article Medicine, General & Internal

Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study

IM Stratton et al.

BMJ-BRITISH MEDICAL JOURNAL (2000)

Add to Collection
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.